
NeuroMetrix NURO
Quartalsbericht 2024-Q3
hinzugefügt 16.05.2026
Land |
|
IPO-Jahr |
2004 |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ GLOBAL |
Anteile |
1.97 M |
Marktkapitalisierung |
$ 9.02 M |
EBITDA (LTM) |
$ -8.61 M |
P/E (LTM) |
- |
P/S (LTM) |
2.47 |
EPS (LTM) |
-3.37 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 68.2 | -0.61 % | $ 13.6 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 122.5 | -3.04 % | $ 7.01 B | NYSE,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 66.68 | -1.8 % | $ 40.4 B | NYSE | ||
|
Intuitive Surgical
ISRG
|
$ 417.82 | -2.06 % | $ 149 B | Nasdaq Global Select Market,SPB | ||
|
ICU Medical
ICUI
|
$ 143.17 | 0.82 % | $ 3.53 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 115.19 | 1.19 % | $ 3.69 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.97 | -0.74 % | $ 183 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
LeMaitre Vascular
LMAT
|
$ 94.48 | -2.18 % | $ 2.14 B | Nasdaq Global Market,SPB | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Masimo Corporation
MASI
|
$ 179.95 | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.8 | -1.1 % | $ 82.4 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Milestone Scientific
MLSS
|
$ 0.39 | 1.28 % | $ 32 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Merit Medical Systems
MMSI
|
$ 67.52 | 0.01 % | $ 3.99 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 10.0 | 5.04 % | $ 84.8 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 24.56 | -0.12 % | $ 4.13 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 79.53 | 1.04 % | $ 3.75 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
STERIS plc
STE
|
$ 209.56 | -1.56 % | $ 20.6 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 29.8 | -0.23 % | $ 1.48 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.88 | -1.66 % | $ 183 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 135.45 | -0.22 % | $ 6.04 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 68.56 | 0.72 % | $ 222 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 331.45 | -0.96 % | $ 24 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 25.2 | -2.21 % | $ 1.7 B | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.33 | -1.3 % | $ 2.06 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.69 | -0.13 % | $ 20.7 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 63.68 | -2.03 % | $ 209 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 27.09 | -1.67 % | $ 1.29 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.85 | -0.27 % | $ 168 M | NYSE American | ||
|
Baxter International
BAX
|
$ 20.62 | 2.95 % | $ 10.6 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 195.39 | -0.79 % | $ 28.5 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 27.27 | -0.13 % | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.3 | 4.3 % | $ 280 M | Nasdaq Global Market | ||
|
AngioDynamics
ANGO
|
$ 12.41 | 0.53 % | $ 507 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 150.4 | -1.08 % | $ 43.3 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.24 | -0.46 % | $ 34.4 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 4.12 | -2.95 % | $ 303 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 133.2 | 2.36 % | $ 7.49 M | Nasdaq Global Select Market,SPB |